4.7 Letter

PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets

Ming Liu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Biotechnology & Applied Microbiology

Poly(ADP-ribose) polymerase inhibition: past, present and future

Nicola J. Curtin et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Article Multidisciplinary Sciences

Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma

Itay Tirosh et al.

NATURE (2016)

Review Medicine, General & Internal

CURRENT CONCEPTS Hepatocellular Carcinoma

Hashem B. El-Serag

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.

Peter C. Fong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Sorafenib in advanced hepatocellular carcinoma

Josep M. Llovet et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)